|
Total.
|
MDR only
|
MDR-FQR
|
MDR-INJR
|
XDR
|
katG
|
rpoB
|
pncA
|
gyrA
|
rrs
|
eis
|
---|
Clone 1
|
67
|
31 (46.3)
|
5 (7.5)
|
4 (6.0)
|
2 (3.0)
|
37 (55.2)
|
39 (58.2)
|
21 (31.3)
|
5 (7.5)
|
4 (6.0)
|
3 (4.5)
|
Clone 2
|
2
|
0 (0.0)
|
0 (0.0)
|
1 (50.0)
|
0 (0.0)
|
1 (50.0)
|
1 (50.0)
|
1 (50.0)
|
1 (50.0)
|
1 (50.0)
|
0 (0.0)
|
Clone 3
|
2
|
1 (50.0)
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
|
1 (50.0)
|
1 (50.0)
|
1 (50.0)
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
|
Clone 4
|
2
|
2 (100.0)
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
|
2 (100.0)
|
2 (100.0)
|
1 (50.0)
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
|
Clone 5
|
2
|
1 (50.0)
|
2 (100.0)
|
0 (0.0)
|
0 (0.0)
|
1 (50.0)
|
1 (50.0)
|
0 (0.0)
|
2 (100.0)
|
0 (0.0)
|
0 (0.0)
|
Clone 6
|
4
|
3 (75.0)
|
1 (25.0)
|
0 (0.0)
|
0 (0.0)
|
4 (100.0)
|
2 (50.0)
|
1 (25.0)
|
0 (0)
|
1 (25.0)
|
0 (0.0)
|
Clone 7
|
2
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
|
1 (50.0)
|
0 (0.0)
|
0 (0.0)
|
Clone 8
|
2
|
1 (50.0)
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
|
1 (50.0)
|
0 (0.0)
|
1 (50.0)
|
0 (0)
|
0 (0.0)
|
0 (0.0)
|
Clone 9
|
2
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
|
1 (50.0)
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
|
1 (50.0)
|
Clone 10
|
2
|
2 (100.0)
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
|
0 (0.0)
|
2 (100.0)
|
0 (0.0)
|
0 (0)
|
0 (0.0)
|
0 (0.0)
|
Clone 11
|
3
|
1 (33.3)
|
1 (33.3)
|
0 (0.0)
|
0 (0.0)
|
3 (100)
|
1 (33.3)
|
1 (33.3)
|
0 (0)
|
0 (0.0)
|
0 (0.0)
|
Singleton
|
44
|
11 (25.0)*
|
0 (0.0)*
|
1 (2.3)
|
0 (0.0)*
|
8 (18.2)*
|
7 (15.9)*
|
12 (27.3)
|
2 (4.5)*
|
1 (2.3)
|
0 (0.0)
|
- MDR multidrug resistance, XDR extensively drug resistance, FQR fluoroquinolones resistance, INJR injective drug resistance
- *p < 0.05 in comparison to the clone group